- Home
- FENC vs TPVG Comparison
FENC vs TPVG Comparison
Compare FENC & TPVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FENC | TPVG |
|---|---|---|
| Founded | 1996 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 230.8M | 224.9M |
| IPO Year | 2010 | 2013 |
Fundamental Metrics
Financial Performance| Metric | FENC | TPVG |
|---|---|---|
| Price | $8.91 | $5.53 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 5 |
| Target Price | ★ $14.50 | $5.90 |
| AVG Volume (30 Days) | ★ 385.5K | 217.7K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 17.66% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.01 | ★ 0.23 |
| Revenue | ★ $44,642,000.00 | N/A |
| Revenue This Year | $65.12 | $7.67 |
| Revenue Next Year | $41.08 | N/A |
| P/E Ratio | $870.00 | ★ $24.17 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.65 | $4.48 |
| 52 Week High | $10.45 | $7.50 |
Technical Indicators
Market Signals| Indicator | FENC | TPVG |
|---|---|---|
| Relative Strength Index (RSI) | 52.69 | 49.88 |
| Support Level | $7.40 | $5.49 |
| Resistance Level | $9.15 | $5.62 |
| Average True Range (ATR) | 0.52 | 0.14 |
| MACD | -0.21 | -0.02 |
| Stochastic Oscillator | 20.41 | 40.51 |
Price Performance
Historical ComparisonAbout FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About TPVG TriplePoint Venture Growth BDC Corp.
TriplePoint Venture Growth BDC Corp is a closed-end, non-diversified management investment company. Its investment objective is to maximize its total return to stockholders in the form of current income and, to a lesser extent, capital appreciation. The fund focuses on companies operating in the fields of biofuels, business applications software, wireless communications equipment, e-commerce, clothing and accessories, conferencing equipment and services, personal goods, financial institutions and services, entertainment, mixed retailing, and healthcare services. Geographically, all the firm's operations are located across the United States.